bucladesine has been researched along with Leukemia, Myeloid in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gineitis, A; Savickiene, J | 1 |
| Alberich Jordà, M; Battista, N; Delwel, R; Löwenberg, B; Maccarrone, M; Rayman, N; Tas, M; van Lom, K; Verbakel, SE | 1 |
| Hayakawa, Y; Ishikawa, T; Niiya, K; Sakuragawa, N; Shinbo, M; Taniguchi, T; Tazawa, S | 1 |
| Dimchev, AB; Ishihara, H; Shikita, M; Tsuneoka, K | 1 |
| Aller, P; Mata, F; Rius, C; Vilaboa, N | 1 |
| Austen, KF; Goetzl, EJ; Lewis, RA; Rubin, RH; Valone, FH; Wasserman, SI | 1 |
| Hescheler, J; Krautwurst, D; Schultz, G; Seifert, R | 1 |
| Buschauer, A; Höer, A; Offermanns, S; Schunack, W; Seifert, R | 1 |
| Hurme, M; Matikainen, S; Serkkola, E | 1 |
| Laskin, DL; Laskin, JD; Robertson, FM; Sirak, AA | 1 |
| Baldwin, GC; Golde, DW; Kitano, K; Raines, MA | 1 |
| Hurme, M; Ronni, T; Serkkola, E; Silvennoinen, O | 1 |
| Cohen, HJ; Currie, MS; Rao, KM; Weinberg, JB | 1 |
| Heiman, DF; Malech, HL | 1 |
| Lopez-Berestein, G; Mehta, K | 1 |
| Haddox, MK; Maddox, AM | 1 |
| Breitman, TR; Hemmi, H | 1 |
| Kaufman, RE; McCachren, SS; Nichols, J; Niedel, JE | 1 |
| Deli, E; Kiss, Z; Kuo, JF | 1 |
19 other study(ies) available for bucladesine and Leukemia, Myeloid
| Article | Year |
|---|---|
3-Deazauridine triggers dose-dependent apoptosis in myeloid leukemia cells and enhances retinoic acid-induced granulocytic differentiation of HL-60 cells.
Topics: 3-Deazauridine; Apoptosis; Bucladesine; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Granulocyte Precursor Cells; Granulocytes; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; Tretinoin | 2003 |
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.
Topics: Acute Disease; Arachidonic Acids; Bucladesine; Cannabinoid Receptor Modulators; Cell Differentiation; Cell Movement; Cyclic AMP; Cyclohexanols; Down-Regulation; Endocannabinoids; Glycerides; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ligands; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Neutrophils; Pertussis Toxin; Receptor, Cannabinoid, CB2; Receptors, Granulocyte Colony-Stimulating Factor | 2004 |
Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
Topics: Bucladesine; Cycloheximide; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid; Plasminogen Activator Inhibitor 2; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured | 1994 |
Induction of the expression of the interleukin-1 beta gene in mouse spleen by ionizing radiation.
Topics: Animals; Bucladesine; Calmodulin; Cesium Radioisotopes; Gene Expression; Genes, fos; Interleukin-1; Leukemia, Myeloid; Male; Mice; Mice, Inbred C3H; Protein Kinase C; Radiation Genetics; Specific Pathogen-Free Organisms; Spleen; Tumor Cells, Cultured; Whole-Body Irradiation | 1993 |
Differential modulation of the expression of the intermediate filament proteins vimentin and nuclear lamins A and C by differentiation inducers in human myeloid leukemia (U-937, HL-60) cells.
Topics: Bucladesine; Butyrates; Butyric Acid; Cell Differentiation; Cytarabine; Gene Expression; Humans; In Vitro Techniques; Lamins; Leukemia, Myeloid; Nuclear Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured; Vimentin | 1993 |
The release of four mediators of immediate hypersensitivity from human leukemic basophils.
Topics: Aged; Antigen-Antibody Reactions; Basophils; Blood Platelets; Bucladesine; Calcium; Carcinoma, Basosquamous; Chemotaxis; Chromatography, Gel; Eosinophils; Histamine; Histamine Release; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Immunoglobulins; Iodine Radioisotopes; Leukemia; Leukemia, Myeloid; Male; Myeloma Proteins; Serotonin; SRS-A; Tritium | 1975 |
Formyl peptides and ATP stimulate Ca2+ and Na+ inward currents through non-selective cation channels via G-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells. Involvement of Ca2+ and Na+ in the activation of beta-glucuronidase release and superox
Topics: Adenosine Triphosphate; Bucladesine; Calcium; Calcium Channels; Cell Differentiation; Enzyme Activation; Fluorescence; Fura-2; Glucuronidase; GTP-Binding Proteins; Humans; Intracellular Fluid; Ion Channels; Leukemia, Myeloid; Manganese; Membrane Potentials; N-Formylmethionine Leucyl-Phenylalanine; Sodium; Sodium Channels; Stimulation, Chemical; Superoxides; Tumor Cells, Cultured | 1992 |
Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
Topics: Betahistine; Bucladesine; Calcium; Cations; Cell Differentiation; Cytosol; Glucuronidase; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Humans; Ion Channels; Leukemia, Experimental; Leukemia, Myeloid; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pertussis Toxin; Phosphorylation; Receptors, Histamine H1; Secretory Rate; Stimulation, Chemical; Superoxides; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tyrosine; Virulence Factors, Bordetella | 1992 |
Retinoic acid enhances IL-1 beta expression in myeloid leukemia cells and in human monocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Blotting, Northern; Bucladesine; Gene Expression; Humans; Interleukin-1; Isoquinolines; Leukemia, Myeloid; Lipopolysaccharides; Monocytes; Piperazines; Protein Kinase Inhibitors; RNA, Messenger; Sulfonamides; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1991 |
Distinct patterns of chemotactic peptide-induced calcium mobilization in differentiated myeloid leukemia cells and peripheral blood neutrophils.
Topics: Biological Transport, Active; Bucladesine; Calcium; Chemotactic Factors; Dose-Response Relationship, Drug; Flow Cytometry; Gallic Acid; Humans; In Vitro Techniques; Leukemia, Myeloid; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Verapamil | 1991 |
Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains.
Topics: Bucladesine; Calcitriol; CD4 Antigens; Cell Differentiation; Cell Line; Dimethyl Sulfoxide; DNA, Viral; Gene Expression; HIV Infections; HIV-1; Humans; Leukemia, Myeloid; Tetradecanoylphorbol Acetate; Thymidine; Tretinoin; Tritium; Virus Replication | 1990 |
Control of interleukin-1 beta expression by protein kinase C and cyclic adenosine monophosphate in myeloid leukemia cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Bucladesine; Colforsin; Cyclic AMP; Dinoprostone; Enzyme Activation; Gene Expression; Humans; Interleukin-1; Isoquinolines; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Piperazines; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1990 |
Chemotactic peptide receptor-cytoskeletal interactions and functional correlations in differentiated HL-60 cells and human polymorphonuclear leukocytes.
Topics: Bucladesine; Cell Differentiation; Cholera Toxin; Cytoskeleton; Interferon-gamma; Leukemia, Myeloid; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Formyl Peptide; Receptors, Immunologic; Superoxides; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Virulence Factors, Bordetella | 1989 |
Swainsonine induced modification of N-linked oligosaccharides on human phagocytic cell formyl peptide chemotactic receptors.
Topics: Alkaloids; Bucladesine; Cell Differentiation; Cycloheximide; Electrophoresis, Polyacrylamide Gel; Glycoside Hydrolases; Humans; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Macrophages; Molecular Weight; N-Formylmethionine Leucyl-Phenylalanine; Oligosaccharides; Phagocytes; Receptors, Formyl Peptide; Receptors, Immunologic; Swainsonine; Tumor Cells, Cultured | 1987 |
Expression of tissue transglutaminase in cultured monocytic leukemia (THP-1) cells during differentiation.
Topics: Bucladesine; Cell Differentiation; Dimethyl Sulfoxide; Humans; Immunosorbent Techniques; Interferon-gamma; Leukemia, Myeloid; Macrophages; Phagocytosis; Recombinant Proteins; Tetradecanoylphorbol Acetate; Transglutaminases; Tretinoin; Vitamin A | 1986 |
Characteristics of cyclic AMP enhancement of retinoic acid induction of increased transglutaminase activity in HL60 cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Alprostadil; Bucladesine; Butyrates; Butyric Acid; Cell Division; Cyclic AMP; Dinoprostone; Enzyme Induction; Humans; Leukemia, Myeloid; Theophylline; Transglutaminases; Tretinoin; Tumor Cells, Cultured | 1988 |
Induction of functional differentiation of a human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin.
Topics: 5'-Nucleotidase; Bucladesine; Cell Differentiation; Cell Line; Cholera Toxin; Culture Media; Dinoprostone; Drug Synergism; Glycoproteins; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Leukemia, Myeloid; Lymphokines; NAD+ Nucleosidase; Nucleotidases; Prostaglandins E; Tretinoin | 1985 |
Dibutyryl cyclic adenosine monophosphate reduces expression of c-myc during HL-60 differentiation.
Topics: Bucladesine; Butyrates; Cell Differentiation; Cell Line; Drug Synergism; Humans; Leukemia, Experimental; Leukemia, Myeloid; Oncogenes; Phenotype; Time Factors | 1986 |
Cyclic AMP-like effects of polyamines on phosphatidylcholine synthesis and protein phosphorylation in human promyelocytic leukemia HL60 cells. Comparison with the effects of phorbol ester.
Topics: Bucladesine; Cell Line; Cyclic AMP; Drug Synergism; Humans; Leukemia, Myeloid; Phosphatidylcholines; Phosphoproteins; Phosphorylation; Polyamines; Protein Kinase C; Protein Kinases; Putrescine; Spermine; Tetradecanoylphorbol Acetate | 1987 |